Page last updated: 2024-10-24

verapamil and Deafness

verapamil has been researched along with Deafness in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhuravskii, SG1
Lopotko, AI1
Tomson, VV1
Ivanov, AG1
Chomskii, AN1
Nurskii, KV1

Other Studies

1 other study available for verapamil and Deafness

ArticleYear
Protective effect of calcium channel blocker verapamil on morphological and functional state of hair cells of the organ of corti in experimental kanamycin-induced ototoxicity.
    Bulletin of experimental biology and medicine, 2002, Volume: 133, Issue:4

    Topics: Animals; Calcium Channel Blockers; Deafness; Kanamycin; Male; Organ of Corti; Rats; Verapamil

2002